John Ricci

EvoShare makes it possible for the everyday person to contribute to their chosen financial savings account via earned cash-back from everyday spending. EvoShare users receive up to 20% cash back toward a financial account such as a 401(k) or 403(b) plan, IRA, HSA, ESA, student loan, 529 plan or emergency savings account. EvoShare has been featured in Forbes, Inc., Entrepreneur, and The Huffington Post. It won the 2019 DC Genie Award from 401(k) TV for “Best Financial Technology” and was a finalist for KNect365’s 2019 Finovate Award for “Top Emerging Tech Company.”  Email us at info@evoshare.com or call (800) 828-9501 to learn more.

Linqto is a pioneering fintech company simplifying private market investments for accredited investors. Based in Silicon Valley, our user-friendly platform provides direct access to private securities in top private companies. Our mission is to remove barriers to private investing, making it as accessible and transparent as possible. Founded on the values of innovation, transparency, and customer-centricity, Linqto empowers individual investors by offering opportunities traditionally reserved for institutions. Our platform ensures a seamless experience, enabling users to invest in high-growth private companies with ease and confidence. We offer secure, convenient and streamline transactions, supported by a dedicated team committed to client success. Whether you’re an experienced investor or new to private markets, our platform provides the tools and insights needed for informed investment decisions. Join us in breaking down barriers to private market investing and unlocking new financial growth opportunities. More Info: linktr.ee/linqto

VENTURE Forum: Empowering investors to discover and fund the next generation of groundbreaking companies, while accelerating startup growth by connecting founders with the right capital and strategic partners. Join us for the SUMMER 2026 DIGITAL VENTURE Forum (July 6 - 10, 2026) to showcase your startup to a global network of investors, or explore our curated selection of high-potential companies seeking funding. For more details: https://ventureforum.net/ Where Innovators and Disruptors meet Investors #venturecapital #startups #innovation #investing #VentureForum

Kyto Technology and Life Science, Inc., formerly Kyto Biopharma, Inc., seeks to develop a specialized vehicle for early stage technology and life science companies. The Company operates as a mentor, advisor, external manager and investor for selected privately held companies in the United States of America, Canada and Israel. The Companys portfolio includes CNote Group, Inc. (CNote), Exodos/Achelios Therapeutics, Inc. (Achelios), Seal Rock Therapeutics, Inc., and Crater, LLC (Crater). CNote provides an alternative savings product that pays up to 35x the interest of a traditional savings account. Crater provides the SurveyBot software program, which enables video chat between a moving companys representative and the customer. Achelios is a specialty pharmaceutical company with primary focus on new therapeutic entity (NTE) development for the treatment of pain and inflammation by delivered medications.

K2X Capital is an evergreen global investment fund expanding access to smarter, diversified investments. We apply a rigorous, double-vetting investment protocol with guidance from a team of ~120 advisors and investors. Weve built a growing portfolio of 90 companies across the US, Canada, India, and Israel.